Member Info for Vanilla

I guess so PR but what pugg1ey says is correct so might see rns soon regarding holdings. It's about 3% dilution so you would expect small drop in share price but the market seems to gobble these up in good times and the share price continues its upwards march. I'd be surprised if directors sell before some of the good news arrives though.

Be interesting to know what the expiry date of the options was as you normally have 6 months from that date to exercise them or lose them. Plus they can only trade them outside of closed periods. Normally you would sell them on exercise and pocket the difference so you don't actually have to outlay any cash so the idea would be to sell them in that 6 month window at the highest price you thought they would get to.....or just buy them at 5p and hold.

Hayashi those itm and ceres valuations are of the scale it's amazing what the global push for new energy can do to these companies sp. Hope we can benefit on the back of some of this as the sp will rise to something that has no relation whatsoever to its turnover. Not really expecting those kind of valuations but wouldn't mind a bit of hype.

I know open but there were far fewer shares which is why old sp values aren't really a good comparison and mc is a far better measure hence the 10p comment based on current number of shares making todays value similar to what it was back in 2006.

The good news just keeps rolling in. Not really sure what to make of this share at the moment but as ever will hang in there to the bitter end if needs be as in my experience it usually pays off just need masses of patience.

When cpx floated in 2006 it was valued at £45m. Whilst prior to the murata news not much progress was made the current position heading into the new year is potentially worth much more & that's why many here have high sp expectations. I do think we will need confirmation of contracts though to achieve those prices but can see this going above 10p based on current announcements.

If this gets some press coverage things may become a bit volatile but seems that most here know its true value. Loooking forward to the next few months and will need to really think really hard about a target price to sell a few. Hopefully 20p then 30p and 50p all out but who knows things can change very quickly on AIM.

If history repeats itself his could go quite high.......need a plan to exit so don't end up tortured like some here. I think this time we are going to get good news on a few fronts which will make it difficult to walk away from this share

Alistair's turned into a trader & ended up with 120k more shares

I've ended up with a ton of these as kept buying on the way down from 18p to lower my average. Wish i would of sold at the top and ended up with free shares like some but always intended to be a lth as not willing to risk being caught out of big rises. Still believe this can way exceed last big rise when nothing materialised as this time it looks like AK will finally deliver. I too can't see the logic of bailing out now after waiting so long and will have an interesting dilemma when we get to 20p

There's a lot of good news in the pipeline to look forward to. I would expect some new orders to be signed soon for ex murata products to secure production slots being as it will be fully up and running in January and signs are that demand will exceed capacity.

Perdita actually said MS can multiplex which may mean run 2 tests simultaneously. These could be affimer and another readily available flu detection test. Not sure but the word multiplex implies the MS doing the dual test rather than the detection substance differentiating between 2 viruses.

I guess that's why with the successful completion of the murata project and the possibility of significant licence news many feel a share price of 20p is not unrealistic

Timster......succinctly put and spot on. It really couldn't be any clearer and just have to wait to see how the story unfolds as frustrating as that can be with all these orders flying around. I'm sure we'll get our share although perhaps not as much as would of been with a midsummer product launch.

DF......the following is a paragraph from 7th aug rns

LSTM is currently evaluating the performance of prototype lateral flow tests provided by Cytiva alongside Avacta's ELISA laboratory test using SARS-CoV-2 coronavirus samples, as a precursor to full clinical validation studies.

The following paragraph is from the 6th aug rns regarding BBI.

Avacta aims to begin clinical validation of the test as soon as possible by using the first pilot batches generated as part of the technology transfer process for these studies.

The following paragraph is from the 2nd sept rns regarding Abingdon.

Avacta aims to begin clinical validation of the test as soon as possible using the first pilot batches.

It looks to me that Cytiva produced some initial samples that have been sent to LSTM that have probably provided an early indication of S&S. These results will be used to assist Condors validation but this will not be completed until BBI produce the samples for them to evaluate and from the last rns it looks like this has not yet happened. Abingdon will only produce the validated product when it has been approved by Condor. I would think that as soon as the samples are produced the validation process will be fairly quick........after all it's a 10min test!

Good advice doh85 i'll be happy if news arrives sometime in September

DOH85.....i think someone mentioned it would have been rns'd which makes sense but don't know for sure

No.......but would be interesing to know if and why mologic haven't used affimers

DOH85.....don't think we know for sure but doesn't appear to be any avct/mologic news since 2016 and odx more recently announced antigen based test partnership with mologic so it is assumed to be odx technology maybe

Yorkshire......if you read through the whole thread you will find out its antigen based in partnership with odx. There's lots of useful information provided but the key thing is that it looks like production won't be until the end of the year and the market is massive. Any positive news from avacta will still be huge.